We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.25 | 1.10 | 1.40 | 1.25 | 1.25 | 1.25 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.57 | 1.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/9/2023 22:17 | Dave for one I am completely aware cruk are/have been a customer. You completely or deliberately missed my point ! CAPS LOCK AGAIN SO YOU LISTEN. What are CRUK working on Davet? | criticalthinker1 | |
22/9/2023 22:00 | Yes, and ill repeat, pyc only charge 35k per drug, and hardly get any business because there are much larger, more advanced Biotech companies that do what pyc do, but much better, and faster, with more advanced tech...and also do it for all drugs, not only cancer drugs. Pyc has no skills for DDR. Even Merck, pycs main customer has teamed up with Artios instead to do all their DDR modelling for cancer drugs. 'Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response. Merck KGaA, Darmstadt, Germany and Artios will conduct collaborative research and Merck KGaA, Darmstadt, Germany shall have the right to opt into exclusive development and commercialization of compounds on up to 8 targets Artios to receive US$30 million in up-front and near-term payments, plus double-digit option fees and up to US$860 million total milestones per target Collaboration to leverage significant expertise and R&D resources of Merck KGaA, Darmstadt, Germany in the field of DNA Damage Response to identify and develop precision oncology medicines targeting nucleases ' Remember, pycs tech is very antiquated. Their virtual tumour software is twenty years old. You weren't even aware cruk was an existing client, admit it. | davevt | |
22/9/2023 21:20 | Yes the socks certainly serve a purpose, the shoes would be a tad uncomfortable without them. | 1347 | |
22/9/2023 21:09 | Dave t. I'm not sure if you are as informed as you believe. You do realise that CRUK fund other research companies right? Such as ICR and not to mention involvement with CRT. THESE COMPANIES HAVE MULTIPLE PIPELINES IN PROGRESS OF WHICH SOME ARE VERY RELEVANT RE DDR AND CYTOKINE STORMS. Turning off Caplock now. If you Davet cannot critically think what is occurring in the pharma world and just negate an honest comment with a derogatory/ill informed response, then I question your modus operandi. I hope you bought today...or back in early July when I did. Ps don't take it out on the socks. They serve a purpose. You seem not to serve anyone apart from yourself. | criticalthinker1 | |
22/9/2023 20:33 | It doesn't matter what CRUK have, pyc charge around £35k per drug they are asked to dose. CRUK have used pyc twice in the past 5 years, and neither of them, we know if pyc even charged them. Do the math. Why do you think pyc does such low revenues. It's only a 35 grand service. | davevt | |
22/9/2023 18:51 | Davet. I know that thankyou very much. You seem some what agitated. I'm talking about what cruk have in the offing, not what is the past. Being overtly dismissive is a tell of someone getting burnt. | criticalthinker1 | |
22/9/2023 18:18 | Cheer up Dave for fox sake | intoodeep | |
22/9/2023 17:48 | You haven't done your DD...if you did, you'd know CRUK is already an existing client of pyc....and pyc has been doing what it does for 20 YEARS. Yes, TWENTY YEARS. | davevt | |
22/9/2023 17:35 | As I said last month and before...don't underestimate cruk and also another company that will be needing similar services to pyc which just could be the biggest thing since slice bread! I've done my dd and If I'm right and the stars align then this will make national news | criticalthinker1 | |
22/9/2023 16:09 | Dnt be mugs and buy now it's suicide | firestarter1 | |
22/9/2023 16:07 | Dnt get caught placing 1.8p | firestarter1 | |
22/9/2023 15:06 | 2.9 million buy at 2.7p. Nice :-) | lukic | |
22/9/2023 13:26 | Maybe a 70% rise today ..? | blueball | |
22/9/2023 13:01 | And we all know Riddler is a TR1 holder. | shortcpx | |
22/9/2023 11:19 | Could be a 30% day...maybe a 50% today. | blueball | |
22/9/2023 07:46 | Stig you can talk, you are known as the biggest scammes pump and dump merchant of any stock, with your stockonomist account on twitter and you created the telegram group 🤣🤣 | davevt | |
22/9/2023 07:37 | Nothing against Transmen or Transwomen but Laura/riddler is such a pathetic pump and dump merchant No RNS from Physiomics at 0700 ? Never mind Laura/Riddler will try to invent some news or reheat some old news or try to encourage other posters' pathetic ramping attempts at 0703 and 0705 Another one of his tricks is to go on whichever the top riser is that day and claim that he is selling it to buy PYC (often when he has never posted on that other stock before!) Riddler we all know you are 'Laura' you lying duplicitous scumbag | the stigologist | |
21/9/2023 21:44 | Tees, pyc wouldn't get a look in because they don't do drug discovery, or use a.i. BenevolentAI helps actually discover drugs, all drugs for all diseases. All pyc does is work out the best dose of an already working cancer drug. Absolutely world's apart. | davevt | |
21/9/2023 21:25 | I have put the profits from UKOG into HERE PYC on a Tip from you-know-who ! GLA VVVVVLTHers! VIVA!!!! 🤣 🤣 🤣 | jack4691 | |
21/9/2023 19:23 | It looks like Merck KGaA are on the hunt for artificial intelligence enabled future for drug discovery.Their recent collaborations with BenevolentAI and Exscientia are interesting. Of course, Physiomics won't even get a look in? Dr Millen should have been prepared and ready for such opportunities. He's sorry! "It looks like we're not gonna get there." TMK | tees maar khan | |
21/9/2023 15:30 | Now, now, children have some patience. Wait for the RNS due anytime in the next few days! In the meantime BUY, BUY, BUY, Bye Bye ! 🤣 | kemche | |
21/9/2023 14:44 | Parob, if you think apta has potential to multibag, then you really should be keeping that to yourself. | davevt | |
21/9/2023 14:39 | Laura is fortunate to hold FCS down 30% today. | blueball |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions